Literature DB >> 12687549

Inhibition of furin-like enzymes blocks interleukin-1alpha/oncostatin M-stimulated cartilage degradation.

J M Milner1, A D Rowan, S-F Elliott, T E Cawston.   

Abstract

OBJECTIVE: To investigate the role of furin-like enzymes in the proteolytic cascades leading to cartilage breakdown and to examine which collagenase(s) contribute to collagen degradation.
METHODS: Bovine nasal cartilage was stimulated to resorb with the addition of interleukin-1alpha (IL-1alpha)/oncostatin M (OSM) in the presence or absence of a furin inhibitor, Dec-RVKR-CH(2)Cl, or selective matrix metalloproteinase 1 (MMP-1) inhibitors. Collagen and proteoglycan levels were determined by assay of hydroxyproline and sulfated glycosaminoglycan, respectively. Collagenase and gelatinase activity were measured using (3)H-acetylated collagen and gelatin zymography, respectively.
RESULTS: The addition of Dec-RVKR-CH(2)Cl to stimulated cartilage reduced the release of collagen fragments and the levels of active collagenase and MMP-2, suggesting that furin-like enzymes are involved in the cascades leading to activation of procollagenases. At MMP inhibitor concentrations that selectively inhibit MMP-1, no inhibition of collagen release was observed, but increasing the concentration to the 50% inhibition concentration for MMP-13 resulted in a 50% blockage of collagen release. The addition of Dec-RVKR-CH(2)Cl to resorbing cartilage also partially blocked proteoglycan release, thus demonstrating a role for furin-activated enzymes in the pathways leading to proteoglycan degradation.
CONCLUSION: Furin-like enzymes are involved in cascades leading to activation of procollagenases and degradation of collagen. MMP-13, which can be activated by furin-processed membrane-type 1 MMP-1, appears to be a major collagenase involved in collagen degradation induced by IL-1alpha/OSM. Furin-like enzymes also appear to play a role in the pathways leading to proteoglycan degradation. These findings are of importance when considering proteinase inhibition as a target for therapeutic intervention in arthritic diseases.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12687549     DOI: 10.1002/art.10873

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  16 in total

Review 1.  Inhibitors of proprotein convertases.

Authors:  Ajoy Basak
Journal:  J Mol Med (Berl)       Date:  2005-10-08       Impact factor: 4.599

2.  2-Methoxystypandrone represses RANKL-mediated osteoclastogenesis by down-regulating formation of TRAF6-TAK1 signalling complexes.

Authors:  W F Chiou; J F Liao; C Y Huang; C C Chen
Journal:  Br J Pharmacol       Date:  2010-09       Impact factor: 8.739

3.  Oncostatin M in combination with tumour necrosis factor {alpha} induces a chondrocyte membrane associated aggrecanase that is distinct from ADAMTS aggrecanase-1 or -2.

Authors:  W Hui; H E Barksby; D A Young; T E Cawston; N McKie; A D Rowan
Journal:  Ann Rheum Dis       Date:  2005-05-05       Impact factor: 19.103

Review 4.  Genetically Engineered Mouse Models Reveal the Importance of Proteases as Osteoarthritis Drug Targets.

Authors:  Rachel E Miller; Yongzhi Lu; Micky D Tortorella; Anne-Marie Malfait
Journal:  Curr Rheumatol Rep       Date:  2013-08       Impact factor: 4.592

Review 5.  Serine proteinases in the turnover of the cartilage extracellular matrix in the joint: implications for therapeutics.

Authors:  David J Wilkinson; Maria Del Carmen Arques; Carmen Huesa; Andrew D Rowan
Journal:  Br J Pharmacol       Date:  2018-03-30       Impact factor: 8.739

6.  Histone deacetylase inhibitors modulate metalloproteinase gene expression in chondrocytes and block cartilage resorption.

Authors:  David A Young; Rachel L Lakey; Caroline J Pennington; Debra Jones; Lara Kevorkian; Dylan R Edwards; Timothy E Cawston; Ian M Clark
Journal:  Arthritis Res Ther       Date:  2005-02-22       Impact factor: 5.156

7.  Metalloproteinase and inhibitor expression profiling of resorbing cartilage reveals pro-collagenase activation as a critical step for collagenolysis.

Authors:  Jennifer M Milner; Andrew D Rowan; Tim E Cawston; David A Young
Journal:  Arthritis Res Ther       Date:  2006       Impact factor: 5.156

8.  Fibroblast activation protein alpha is expressed by chondrocytes following a pro-inflammatory stimulus and is elevated in osteoarthritis.

Authors:  Jennifer M Milner; Lara Kevorkian; David A Young; Debra Jones; Robin Wait; Simon T Donell; Emma Barksby; Angela M Patterson; Jim Middleton; Benjamin F Cravatt; Ian M Clark; Andrew D Rowan; Timothy E Cawston
Journal:  Arthritis Res Ther       Date:  2006-01-03       Impact factor: 5.156

9.  Exogenous sphingomyelinase increases collagen and sulphated glycosaminoglycan production by primary articular chondrocytes: an in vitro study.

Authors:  Sophie J Gilbert; Emma J Blain; Pamela Jones; Victor C Duance; Deborah J Mason
Journal:  Arthritis Res Ther       Date:  2006       Impact factor: 5.156

Review 10.  Proteases involved in cartilage matrix degradation in osteoarthritis.

Authors:  Linda Troeberg; Hideaki Nagase
Journal:  Biochim Biophys Acta       Date:  2011-07-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.